Early Antiviral Therapy and Lymphoma Risk in Chronic HCV Early Antiviral Therapy and Lymphoma Risk in Chronic HCV
Chronic HCV infection has been linked to lymphoproliferative disorders. Can early PegIFN/RBV therapy reduce the risk?Alimentary Pharmacology & Therapeutics
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
More News: Antiviral Therapy | Drugs & Pharmacology | Gastroenterology | HIV AIDS | Infectious Diseases | Lymphoma